Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Senti Biosciences (SNTI) Asset Writedowns and Impairment (2023 - 2025)

Senti Biosciences has reported Asset Writedowns and Impairment over the past 3 years, most recently at $5.1 million for Q4 2025.

  • For Q4 2025, Asset Writedowns and Impairment rose 1584.0% year-over-year to $5.1 million; the TTM value through Dec 2025 reached $5.6 million, down 78.59%, while the annual FY2025 figure was $5.1 million, 1514.06% up from the prior year.
  • Asset Writedowns and Impairment for Q4 2025 was $5.1 million at Senti Biosciences, up from $300000.0 in the prior quarter.
  • Over five years, Asset Writedowns and Impairment peaked at $25.7 million in Q3 2023 and troughed at $271000.0 in Q4 2023.
  • A 3-year average of $7.8 million and a median of $2.7 million in 2024 define the central range for Asset Writedowns and Impairment.
  • Biggest five-year swings in Asset Writedowns and Impairment: increased 10.7% in 2024 and later skyrocketed 1584.0% in 2025.
  • Year by year, Asset Writedowns and Impairment stood at $271000.0 in 2023, then grew by 10.7% to $300000.0 in 2024, then skyrocketed by 1584.0% to $5.1 million in 2025.
  • Business Quant data shows Asset Writedowns and Impairment for SNTI at $5.1 million in Q4 2025, $300000.0 in Q4 2024, and $271000.0 in Q4 2023.